275 related articles for article (PubMed ID: 31533918)
1. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.
Koehn BH; Saha A; McDonald-Hyman C; Loschi M; Thangavelu G; Ma L; Zaiken M; Dysthe J; Krepps W; Panthera J; Hippen K; Jameson SC; Miller JS; Cooper MA; Farady CJ; Iwawaki T; Ting JP; Serody JS; Murphy WJ; Hill GR; Murray PJ; Bronte V; Munn DH; Zeiser R; Blazar BR
Blood; 2019 Nov; 134(19):1670-1682. PubMed ID: 31533918
[TBL] [Abstract][Full Text] [Related]
2. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.
Koehn BH; Apostolova P; Haverkamp JM; Miller JS; McCullar V; Tolar J; Munn DH; Murphy WJ; Brickey WJ; Serody JS; Gabrilovich DI; Bronte V; Murray PJ; Ting JP; Zeiser R; Blazar BR
Blood; 2015 Sep; 126(13):1621-8. PubMed ID: 26265697
[TBL] [Abstract][Full Text] [Related]
3. IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sjögren's syndrome.
Xia X; Long Q; Zha J; Jiang T; Guo J; Jiang B; Li X; Yao G
Int Immunol; 2023 Nov; 35(11):531-542. PubMed ID: 37756640
[TBL] [Abstract][Full Text] [Related]
4. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
[TBL] [Abstract][Full Text] [Related]
6. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
[TBL] [Abstract][Full Text] [Related]
7. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
van Deventer HW; Burgents JE; Wu QP; Woodford RM; Brickey WJ; Allen IC; McElvania-Tekippe E; Serody JS; Ting JP
Cancer Res; 2010 Dec; 70(24):10161-9. PubMed ID: 21159638
[TBL] [Abstract][Full Text] [Related]
8. MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes.
Zhu Y; Chen P; Hu B; Zhong S; Yan K; Wu Y; Li S; Yang Y; Xu Z; Lu Y; Ouyang Y; Bao H; Gu W; Wen L; Zhang Y
Biomaterials; 2024 Jun; 307():122533. PubMed ID: 38493671
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
[TBL] [Abstract][Full Text] [Related]
10. Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression.
Papafragkos I; Grigoriou M; Boon L; Kloetgen A; Hatzioannou A; Verginis P
Front Immunol; 2022; 13():889075. PubMed ID: 36032139
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
[TBL] [Abstract][Full Text] [Related]
12. Candida tropicalis induces NLRP3 inflammasome activation via glycogen metabolism-dependent glycolysis and JAK-STAT1 signaling pathway in myeloid-derived suppressor cells to promote colorectal carcinogenesis.
Zhang Z; Chen Y; Yin Y; Chen Y; Chen Q; Bing Z; Zheng Y; Hou Y; Shen S; Chen Y; Wang T
Int Immunopharmacol; 2022 Dec; 113(Pt B):109430. PubMed ID: 36384075
[TBL] [Abstract][Full Text] [Related]
13. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
Chen K; Zhang J; Zhang W; Zhang J; Yang J; Li K; He Y
Int J Biochem Cell Biol; 2013 May; 45(5):932-43. PubMed ID: 23434541
[TBL] [Abstract][Full Text] [Related]
14. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
Front Immunol; 2021; 12():661323. PubMed ID: 34531850
[TBL] [Abstract][Full Text] [Related]
15. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts.
Liu H; Yeung WHO; Pang L; Liu J; Liu XB; Pan Ng KT; Zhang Q; Qiu WQ; Zhu Y; Ding T; Wang Z; Zhu JY; Lo CM; Man K
JHEP Rep; 2023 Dec; 5(12):100895. PubMed ID: 37916155
[TBL] [Abstract][Full Text] [Related]
17. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
19. The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance.
Li J; Chen J; Zhang M; Zhang C; Wu R; Yang T; Qiu Y; Liu J; Zhu T; Zhang Y; Rong R
Front Immunol; 2021; 12():661338. PubMed ID: 33897705
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts.
Zhang A; Wang P; Ma X; Yin X; Li J; Wang H; Jiang W; Jia Q; Ni L
Mol Immunol; 2015 Aug; 66(2):253-62. PubMed ID: 25863775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
